Non-steroidal Anti-inflammatory Drugs and Hypertension
Authors:
- 16 November 2013
- journal article
- review article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 69 (2) , 209-211
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to alleviate pain of the patients who suffer from inflammatory conditions like rheumatoid arthritis, osteoarthritis, and other painful conditions like gout. This class of drugs works by blocking cyclooxgenases which in turn block the prostaglandin production in the body. Most often, NSAIDs and antihypertensive drugs are used at the same time, and their use increases with increasing age. Moreover, hypertension and arthritis are common in the elderly patients requiring pharmacological managements. An ample amount of studies put forth evidence that NSAIDs reduce the efficiency of antihypertensive drugs plus aggravate pre-existing hypertension or make the individuals prone to develop high blood pressure through renal dysfunction. This review will help doctors to consider the effects and risk factors of concomitant prescription of NSAIDs and hypertensive drugs.Keywords
This publication has 18 references indexed in Scilit:
- Membranous Nephropathy and Nonsteroidal Anti-inflammatory AgentsAmerican Journal of Kidney Diseases, 2013
- Diclofenac induced acute renal failure in a decompensated elderly patientJournal of Pharmacology and Pharmacotherapeutics, 2013
- Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugsBMC Gastroenterology, 2013
- Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertensionBMC Cardiovascular Disorders, 2012
- The Role ofHelicobacter pyloriand NSAIDs in the Pathogenesis of Uncomplicated Duodenal UlcerGastroenterology Research and Practice, 2012
- Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case–control study in a new general practice databaseEuropean Journal of Clinical Pharmacology, 2012
- Diabetes and Hypertension: Is There a Common Metabolic Pathway?Current Atherosclerosis Reports, 2012
- Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature, 2012
- Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control studyBMJ, 2012
- Microsomal Prostaglandin E2 Synthase: A Safer Target than Cyclooxygenases?Molecular Interventions, 2007